The latest keyword outbreaks include proprotein convertase subtilisin, inflammation, bempedoic acid, and inclisiran, which could be potential frontiers in the field of cardiovascular disease and PCSK9 research. This evidence concerns the gene PCSK9 and cardiovascular disorder.